Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Allergan, Inc.    AGN   US0184901025


News SummaryMost relevantAll newsSector news 

Allergan, Inc. : Allergan Gets Subpoena From Government Over Lap-Band System

05/07/2012 | 06:11pm US/Eastern
   By Anjali Athavaley 

Allergan Inc. (AGN) received a subpoena this month from the Department of Health and Human Services requesting documents related to the company's Lap-Band System for obesity, according to a filing.

Lap-Band is approved to help obese patients lose weight. It is inserted surgically through a small incision and placed at the top of the stomach. The inflatable band can be tightened or loosened to reduce or enlarge stomach capacity.

An Allergan spokeswoman declined to comment further.

Earlier this month, Allergan said its first-quarter earnings rose 45% on double-digit sales growth in its specialty-pharmaceuticals business. But sales in Allergan's obesity intervention category slipped 15.5% as high unemployment, lofty co-payments and rigid requirements from insurers pressured sales.

Last December, the U.S. Food and Drug Administration warned nine groups, mostly surgical centers in California, that if they continue misleading advertising for Lap-Band, they could face monetary penalties and have inventory seized. The FDA made no allegations against Allergan at the time.

Allergan shares were up fractionally to $93.79 in after-hours trading Monday. The stock is up nearly 7% so far this year.

-By Anjali Athavaley, Dow Jones Newswires; 212-416-4912;

React to this article
Latest news on ALLERGAN, INC.
02/27 ALLERGAN : FDA Approves Allergan's NATRELLE INSPIRA™ Round Gel-Filled Brea..
02/27 ALLERGAN : FDA Approves Allergan’s NATRELLE INSPIRA™ Round Gel-Fille..
02/26 ACTAVIS : Announces Intention to Adopt "Allergan" Corporate Name
02/25 ALLERGAN : Actavis Announces Proposed Public Offerings of Ordinary Shares and Ma..
02/25 ALLERGAN, INC. : ex-dividend day
02/23 ALLERGAN : Valeant Pharmaceuticals Reports Fourth Quarter And Full Year 2014 Fin..
02/23 Canada’s Valeant to acquire Salix in $10.1 billion deal
02/22 Valeant agrees to buy Salix for about $10 billion in cash
02/20DJValeant Approved to Buy Dendreon Assets for $495 Million
02/20 Drugmaker Valeant close to buying Salix - source
Duration : Period :
Allergan, Inc. Technical Analysis Chart | AGN | US0184901025 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes